ASSESSMENT OF IN VITRO STUDIES OF [131I]I-LABELED DEDEYFELV PEPTIDE AS PROSPECTIVE BIOMARKER FOR GLIOBLASTOMA

ASSESSMENT OF IN VITRO STUDIES OF [131I]I-LABELED DEDEYFELV PEPTIDE AS PROSPECTIVE BIOMARKER FOR GLIOBLASTOMA

Introduction/Justification: Glioblastomas (GBM) constitute the most prevalent malignant primary tumor in adults and rank as the third most frequent tumors in the central nervous system. The predominant alteration observed in GBM is associated with the tyrosine-kinase pathway, facilitating the connec...

Full description

Bibliographic Details
Main Authors: Fernanda Paiva Augusto Rodrigues, Júlia Calviello Giordano, Danielle Vieira Sobral, Ana Cláudia Camargo Miranda, Leonardo Lima Fuscaldi, Marycel Figols de Barboza, João Luiz Vitorino Araújo, Luciana Malavolta
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
EGFr-targeting peptide
Glioblastoma
U-87 MG cells
[131I]I-labeled-peptide
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137924001457

Internet

http://www.sciencedirect.com/science/article/pii/S2531137924001457

Similar Items